It upregulates the production of pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-α) and interleukins (IL-1β, IL-6), thereby triggering hepatic fibrosis and necro-inflammatory responses, which ultimately increase the risk of hepatocellular carcinoma [9]. Here, TNF is linked to hepatocellular carcinoma.